HIMS & HERS HEALTH INC (HIMS) Stock Fundamental Analysis
NYSE:HIMS • US4330001060
15.6 USD
-0.22 (-1.39%)
At close: Feb 26, 2026
15.45 USD
-0.15 (-0.96%)
After Hours: 2/26/2026, 8:04:00 PM
Overall HIMS gets a fundamental rating of 4 out of 10. We evaluated HIMS against 101 industry peers in the Health Care Providers & Services industry. There are concerns on the financial health of HIMS while its profitability can be described as average. HIMS has a expensive valuation and it also scores bad on growth.
1. Profitability
1.1 Basic Checks
- In the past year HIMS was profitable.
- HIMS had a positive operating cash flow in the past year.
- HIMS had negative earnings in 4 of the past 5 years.
- The reported operating cash flow has been mixed in the past 5 years: HIMS reported negative operating cash flow in multiple years.
1.2 Ratios
- HIMS has a Return On Assets of 5.99%. This is amongst the best in the industry. HIMS outperforms 82.18% of its industry peers.
- Looking at the Return On Equity, with a value of 23.03%, HIMS belongs to the top of the industry, outperforming 90.10% of the companies in the same industry.
- The Return On Invested Capital of HIMS (5.84%) is better than 62.38% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.99% | ||
| ROE | 23.03% | ||
| ROIC | 5.84% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- The Profit Margin of HIMS (6.05%) is better than 82.18% of its industry peers.
- HIMS has a better Operating Margin (5.96%) than 66.34% of its industry peers.
- With an excellent Gross Margin value of 75.01%, HIMS belongs to the best of the industry, outperforming 90.10% of the companies in the same industry.
- In the last couple of years the Gross Margin of HIMS has grown nicely.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 5.96% | ||
| PM (TTM) | 6.05% | ||
| GM | 75.01% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
2. Health
2.1 Basic Checks
- HIMS has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
- HIMS has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- An Altman-Z score of 2.62 indicates that HIMS is not a great score, but indicates only limited risk for bankruptcy at the moment.
- HIMS has a Altman-Z score (2.62) which is in line with its industry peers.
- The Debt to FCF ratio of HIMS is 8.13, which is on the high side as it means it would take HIMS, 8.13 years of fcf income to pay off all of its debts.
- HIMS has a Debt to FCF ratio (8.13) which is comparable to the rest of the industry.
- A Debt/Equity ratio of 1.67 is on the high side and indicates that HIMS has dependencies on debt financing.
- HIMS has a worse Debt to Equity ratio (1.67) than 69.31% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.67 | ||
| Debt/FCF | 8.13 | ||
| Altman-Z | 2.62 |
ROIC/WACC0.67
WACC8.69%
2.3 Liquidity
- A Current Ratio of 1.88 indicates that HIMS should not have too much problems paying its short term obligations.
- Looking at the Current ratio, with a value of 1.88, HIMS is in the better half of the industry, outperforming 78.22% of the companies in the same industry.
- A Quick Ratio of 1.64 indicates that HIMS should not have too much problems paying its short term obligations.
- Looking at the Quick ratio, with a value of 1.64, HIMS is in the better half of the industry, outperforming 68.32% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.88 | ||
| Quick Ratio | 1.64 |
3. Growth
3.1 Past
- HIMS shows a slight negative growth in Earnings Per Share. In the last year, the EPS has decreased by -7.41%.
EPS 1Y (TTM)-7.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-36.36%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%28.41%
3.2 Future
- Based on estimates for the next years, HIMS will show a very strong growth in Earnings Per Share. The EPS will grow by 51.33% on average per year.
- HIMS is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 12.27% yearly.
EPS Next Y16.28%
EPS Next 2Y26.07%
EPS Next 3Y68.86%
EPS Next 5Y51.33%
Revenue Next Year16.69%
Revenue Next 2Y17.68%
Revenue Next 3Y13.77%
Revenue Next 5Y12.27%
3.3 Evolution
4. Valuation
4.1 Price/Earnings Ratio
- HIMS is valuated quite expensively with a Price/Earnings ratio of 31.20.
- Compared to the rest of the industry, the Price/Earnings ratio of HIMS is on the same level as its industry peers.
- Compared to an average S&P500 Price/Earnings ratio of 27.21, HIMS is valued at the same level.
- HIMS is valuated quite expensively with a Price/Forward Earnings ratio of 26.83.
- Compared to the rest of the industry, the Price/Forward Earnings ratio of HIMS is on the same level as its industry peers.
- HIMS is valuated at similar levels of the S&P average when we compare the Price/Forward Earnings ratio to 28.13, which is the current average of the S&P500 Index.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.2 | ||
| Fwd PE | 26.83 |
4.2 Price Multiples
- The rest of the industry has a similar Enterprise Value to EBITDA ratio as HIMS.
- Compared to the rest of the industry, the Price/Free Cash Flow ratio of HIMS is on the same level as its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 29.72 | ||
| EV/EBITDA | 20.99 |
4.3 Compensation for Growth
- The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates HIMS does not grow enough to justify the current Price/Earnings ratio.
- The decent profitability rating of HIMS may justify a higher PE ratio.
- HIMS's earnings are expected to grow with 68.86% in the coming years. This may justify a more expensive valuation.
PEG (NY)1.92
PEG (5Y)N/A
EPS Next 2Y26.07%
EPS Next 3Y68.86%
5. Dividend
5.1 Amount
- No dividends for HIMS!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
15.6
-0.22 (-1.39%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Providers & Services
Earnings (Last)02-23 2026-02-23/amc
Earnings (Next)05-04 2026-05-04
Inst Owners94.2%
Inst Owner Change-9.84%
Ins Owners5.93%
Ins Owner Change-1.34%
Market Cap3.55B
Revenue(TTM)N/A
Net Income(TTM)133.79M
Analysts67.27
Price Target30 (92.31%)
Short Float %37.45%
Short Ratio3.62
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-16.62%
Min EPS beat(2)-43.53%
Max EPS beat(2)10.29%
EPS beat(4)3
Avg EPS beat(4)8.39%
Min EPS beat(4)-43.53%
Max EPS beat(4)62.17%
EPS beat(8)7
Avg EPS beat(8)149.86%
EPS beat(12)10
Avg EPS beat(12)106.48%
EPS beat(16)12
Avg EPS beat(16)73.87%
Revenue beat(2)1
Avg Revenue beat(2)-0.98%
Min Revenue beat(2)-3.17%
Max Revenue beat(2)1.2%
Revenue beat(4)3
Avg Revenue beat(4)1.27%
Min Revenue beat(4)-3.17%
Max Revenue beat(4)6.75%
Revenue beat(8)6
Avg Revenue beat(8)1.26%
Revenue beat(12)9
Avg Revenue beat(12)1.39%
Revenue beat(16)13
Avg Revenue beat(16)3.12%
PT rev (1m)-2.29%
PT rev (3m)-11.57%
EPS NQ rev (1m)15.33%
EPS NQ rev (3m)-32.54%
EPS NY rev (1m)0.73%
EPS NY rev (3m)-20.78%
Revenue NQ rev (1m)-0.08%
Revenue NQ rev (3m)0.02%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.34%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 31.2 | ||
| Fwd PE | 26.83 | ||
| P/S | 1.61 | ||
| P/FCF | 29.72 | ||
| P/OCF | 10.92 | ||
| P/B | 6.11 | ||
| P/tB | 28 | ||
| EV/EBITDA | 20.99 |
EPS(TTM)0.5
EY3.21%
EPS(NY)0.58
Fwd EY3.73%
FCF(TTM)0.52
FCFY3.36%
OCF(TTM)1.43
OCFY9.15%
SpS9.71
BVpS2.55
TBVpS0.56
PEG (NY)1.92
PEG (5Y)N/A
Graham Number5.36
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 5.99% | ||
| ROE | 23.03% | ||
| ROCE | 7.39% | ||
| ROIC | 5.84% | ||
| ROICexc | 9.03% | ||
| ROICexgc | 14.91% | ||
| OM | 5.96% | ||
| PM (TTM) | 6.05% | ||
| GM | 75.01% | ||
| FCFM | 5.4% |
ROA(3y)-1.82%
ROA(5y)-6.51%
ROE(3y)-0.49%
ROE(5y)-7.04%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y1.84%
GM growth 5YN/A
F-Score3
Asset Turnover0.99
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 1.67 | ||
| Debt/FCF | 8.13 | ||
| Debt/EBITDA | 5.57 | ||
| Cap/Depr | 484.08% | ||
| Cap/Sales | 9.3% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 186.53% | ||
| Profit Quality | 89.31% | ||
| Current Ratio | 1.88 | ||
| Quick Ratio | 1.64 | ||
| Altman-Z | 2.62 |
F-Score3
WACC8.69%
ROIC/WACC0.67
Cap/Depr(3y)228.03%
Cap/Depr(5y)N/A
Cap/Sales(3y)2.66%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-7.41%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-36.36%
EPS Next Y16.28%
EPS Next 2Y26.07%
EPS Next 3Y68.86%
EPS Next 5Y51.33%
Revenue 1Y (TTM)N/A
Revenue growth 3YN/A
Revenue growth 5YN/A
Sales Q2Q%28.41%
Revenue Next Year16.69%
Revenue Next 2Y17.68%
Revenue Next 3Y13.77%
Revenue Next 5Y12.27%
EBIT growth 1Y190.64%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year350.34%
EBIT Next 3Y88.26%
EBIT Next 5Y57.83%
FCF growth 1Y344.61%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y625.93%
OCF growth 3YN/A
OCF growth 5YN/A
HIMS & HERS HEALTH INC / HIMS FAQ
What is the ChartMill fundamental rating of HIMS & HERS HEALTH INC (HIMS) stock?
ChartMill assigns a fundamental rating of 4 / 10 to HIMS.
What is the valuation status of HIMS & HERS HEALTH INC (HIMS) stock?
ChartMill assigns a valuation rating of 3 / 10 to HIMS & HERS HEALTH INC (HIMS). This can be considered as Overvalued.
What is the profitability of HIMS stock?
HIMS & HERS HEALTH INC (HIMS) has a profitability rating of 6 / 10.
What is the financial health of HIMS & HERS HEALTH INC (HIMS) stock?
The financial health rating of HIMS & HERS HEALTH INC (HIMS) is 3 / 10.